Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists Authors Abid M, Sheikh KS, Ahmad MS, Jiang H Received 19 January 2026 Accepted for publication 17 March 2026 Published 12 June 2026 Volume 2026:19 566414 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Donald McClain Mahroz Abid, 1 Khizer Sohail Sheikh, 1 Muhammad Shahbaz Ahmad, 2 Hongwei Jiang 1 1 Department of Metabolism and Endocrinology, Endocrine and Metabolic Disease Center, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Peoples Republic of China
Wegovy was also approved by the FDA in 2022 for obesity and overweight
HPLC amino acid quantification The analysis was conducted using our previously established chromatographic conditions (5) on an Agilent 1260 Infinity II LC System (5)
doi: 10.1113/JP273839 38 WirthR.KdrG.KakukB.MartiG.BagiZ.Szilgyi.et al
As previously reported, 26 we found that JNK is constitutively activated in the control livers of Gstp1/2 / mice as demonstrated by the high amounts of p-JNK
Company Profile FAQ Do you have a price list or product list
